
Episode 73 - MicroRNAs - tiny molecules, powerful diagnostics, early disease detection - Eva Hanks
Canine Arthritis MattersShow Notes
February at Canine Arthritis Matters focuses on identification — and in this episode we explore what early identification of osteoarthritis could look like in the future.
Hannah Capon is joined by Dr Eva Hanks, CEO and founder of MI:RNA, to discuss the emerging role of microRNA (miRNA) biomarkers in detecting canine osteoarthritis at a molecular level.
We know that most dogs are diagnosed with OA once structural damage is already present. Subtle behavioural, postural and gait changes are often missed or dismissed. So what if we could detect disease before radiographic change, before overt lameness, before chronic pain becomes entrenched?
Dr Hanks explains what miRNAs are, how they function biologically, and why they may act as measurable indicators of early pathological change. This conversation explores the human evidence base, the current state of canine research, the challenges of variability between breeds and individuals, and whether the veterinary profession is ready to adopt biomarker technology as part of routine identification strategies.
This is a forward-looking discussion about moving from subjective suspicion to objective identification — and what that could mean for the future of canine osteoarthritis management.
Guest Bio
Dr Eva Hanks is CEO and founder of MI:RNA, a veterinary diagnostics company focused on early disease identification through biomarker technology combined with artificial intelligence. MI:RNA is a spin-out from Scotland’s Rural College (SRUC).
Dr Hanks began her career in busy mixed practice before returning to academia to complete an advanced certificate, followed by a PhD in immunology. She later worked as a clinical pathologist before launching MI:RNA in 2019, bringing together research, clinical insight and diagnostic innovation to improve early disease detection in companion animals.
5 Key Takeaways
1. We currently identify osteoarthritis too late, often after structural joint damage and chronic pain patterns are established. 2. MicroRNAs are regulatory molecules that reflect active biological processes and may allow identification of osteoarthritis at a molecular stage before visible joint changes occur. 3. Human meta-analyses show strong diagnostic accuracy for miRNAs in OA, but robust canine validation is essential before widespread clinical adoption. 4. Objective biomarkers could complement clinical assessment, helping bridge the gap between caregiver-reported subtle changes and definitive diagnosis. 5. Early identification opens the door to earlier lifestyle modification, weight management, activity optimisation and targeted intervention — shifting OA management towards prevention of progression rather than reaction to damage.
Relevant Links
MI:RNA https://www.mirna.co.uk
Scottish Rural College (SRUC) https://www.sruc.ac.uk
Learn more about CAM:
Facebook: https://www.facebook.com/CAMarthritis Instagram: https://www.instagram.com/canine_arthritis Youtube: https://www.youtube.com/c/CanineArthritisManagement LinkedIn: https://www.linkedin.com/company/canine-arthritis-management-ltd
Have questions send them to: [email protected]
Stay tuned to learn how early detection can make a significant difference in managing OA in younger dogs.
More from Canine Arthritis Matters
In this episode of Canine Arthritis Matters, Hannah is joined by animal behaviourist and neuroscience expert Daniel Shaw to explore canine cognitive dysfunction (CCD) and its relationship with chronic pain. They discuss how CCD is often underdiagnosed, why its early signs can be subtle, and how pain, sensory decline and anxiety can mimic or worsen cognitive symptoms. Daniel explains that while age-related brain changes cannot always be prevented, we can support healthy brain function through appropriate physical activity, cognitive and social enrichment, good nutrition and quality sleep. They also explore the importance of adapting activities to each dog's individual needs and recognising that chronic pain and CCD can coexist. The episode highlights the value of a holistic, multidisciplinary approach to helping older dogs maintain their wellbeing and quality of life. 5 Key Take-Home Points CCD is often underdiagnosed: Early signs can be subtle and easily mistaken for normal ageing.
This episode explores the complex relationship between chronic pain, behaviour, movement and the human-animal bond. Hannah is joined by Dr Findy and Elena Wilson to discuss why chronic pain can be difficult to recognise, particularly when behavioural or mobility changes are misinterpreted as training issues, ageing or stubbornness. They explore the importance of understanding the emotional and social impact of pain, supporting caregivers through difficult diagnoses, and recognising that dogs are continually communicating with us. The conversation also highlights the value of true interdisciplinary collaboration, combining veterinary, behavioural and physiotherapy expertise to provide more holistic care. Ultimately, effective chronic pain management goes beyond medication, requiring individualised support, environmental adaptations, appropriate movement, emotional safety and a strong team around both the dog and caregiver. 5 Key Take Home Points Learn to recognise the subtle signs of pain.
In this episode, Hannah chats with Dr Tom Walsh about taking a more holistic, practical approach to canine health and osteoarthritis management. They explore his Corenza approach, built around five key pillars: exercise, environment, enrichment, nutrition and responsibility. Together, they discuss how these areas can help reduce overwhelm for caregivers while supporting dogs at every life stage, including those living with OA. From adapting exercise and improving flooring, to providing meaningful enrichment and navigating the often-confusing world of nutrition, the conversation focuses on seeing the whole dog rather than simply treating individual problems. Above all, they explore how we can help dogs live happier, healthier lives. Buy Dr Tom’s book on amazon “Good Dogs, Broken System: A Veterinarian’s Guide to Rebuilding Trust Through the Coerenza Approach”
This episode explores the emotional wellbeing of dogs, caregivers and veterinary teams, with Tamsin Durston sharing practical ways to create safer, more supportive veterinary experiences. Hannah and Tam discuss the impact of osteoarthritis and chronic disease on both dogs and their caregivers, including anxiety, guilt, grief and caregiver burden. They explore how simple environmental changes, empathetic communication and thoughtful appointment planning can reduce stress and improve psychological safety. The conversation also highlights trigger stacking in veterinary teams and the importance of taking small pauses to reset between patients. Above all, the episode encourages veterinary professionals to recognise caregivers as part of the patient journey, build their confidence and help transform guilt into pride. 5 Key Take-Home Points Psychological safety matters — for dogs, caregivers and veterinary teams.
In this episode, Hannah and Drew explore the changing face of canine osteoarthritis (OA), highlighting why early detection and proactive management are so important. They discuss how OA can develop at a surprisingly young age, often before obvious clinical or radiographic signs appear. Drew explains how objective gait and stance analysis can help identify subtle changes, establish baselines and monitor responses to treatment. The conversation covers multimodal and layered approaches to OA management, including weight management, exercise, lifestyle changes, physiotherapy and intra-articular therapies. Above all, they emphasise that OA management is a journey, requiring regular monitoring, individualised plans and a focus on improving comfort and quality of life. OA can start young — don’t assume it’s just a disease of old age.